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Table. Demographics, comorbidities, hospital covariates, and outcomes
in patients with median arcuate ligament syndrome (MALS) and in those
who undergo celiac artery decompression (CAD)
Variable MALS CAD P
Demographics
Age 67.9 6 15.7 40.9 6 17.4 <.001
Female, % 66.9 73.9 <.001
Chronic conditions, No. 7.3 6 3.1 3.5 6 2.3 <.001
Diagnoses on record, No. 11.3 6 5.3 6.3 6 4.6 <.001
DRG severity of illness 2.7 6 0.7 1.7 6 0.8 <.001
DRG risk of mortality 2.3 6 0.9 1.2 6 0.5 <.001
Comorbidities, %
Iron deﬁciency anemia 19.8 4.7 <.001
Congestive heart failure 11.2 0.0 <.001
COPD 25.1 12.2 <.001
Depression 12.8 9.3 <.01
Diabetes 17.1 3.1 <.001
Hypertension 61.1 22.4 <.001
Fluid and electrolyte
disorders
28.1 9.5 <.001
Peripheral vascular disorder 49.5 14.3 <.001
Renal failure 15.5 0.8 <.001
Weight loss 12.4 10.0 NS
Hospital covariates
Urban hospital location 92.2 97.3 <.001
Teaching hospital 51.5 82.2 <.001
Outcomes
Length of stay, days 5 (3-8) 4 (3-7) NS
Total costs in 2014 US $ $13,129
(7716-22,628)
$16,107
(11,466-23,610)
<.01
Inpatient mortality 2.6 0.0 <.001
COPD, Chronic obstructive pulmonary disease; NS, not signiﬁcant; US,
United States.
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Objectives: Splenic artery aneurysms (SAAs) are rare, with an
overall estimated incidence of <0.01%. Open surgical techniques
have traditionally been used to treat or exclude SAAs. More recently,
endovascular procedures have emerged as a preferred treatment.
However, evidence to support an endovascular management strategy
for SAA is limited to few case series and mostly individual case
reports.
Methods: We used the Nationwide Inpatient Sample (NIS) and
gathered data from 2008 to 2011 to compare open vs endovascular SAA
repair by assessing postoperative outcomes, hospital length of stay, and
mortality.
Results: There were 2316 admissions during the study period
with a diagnosis code for SAA. Among these admissions, 347 pa-
tients (14.9%) underwent endovascular repair and 112 patients
(4.8%) underwent open surgery. There was a statistically signiﬁcantly
lower rate of cardiac (2.3% vs 6.9%; P ¼ .05) and pulmonary (8.9%
vs 16.1%; P ¼ .05) complications in patients undergoing endovascu-
lar repair compared with those undergoing open surgery. In addi-
tion, the risk of surgical site infection in endovascularly treated
SAA was also lower (0.6% vs 5.1%; P ¼ .01). In-hospital length of
stay was signiﬁcantly greater for open repairs than for endovascular
repairs (6 vs 4 days, respectively; P ¼ .01). There were no statisti-
cally signiﬁcant differences across procedures for renal complications
(8.9% in both groups; P ¼ .88) or in-hospital mortality (3% in both
groups; P ¼ .99).
Conclusions: In this observational study, endovascular repair of SAA
is associated with a lower complication rate and less resource utilization but
no difference in mortality perioperatively compared with open surgery.
This may justify an endovascular-ﬁrst treatment strategy in the manage-
ment of SAA.
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